Moreover, sophocarpine was shown to inhibit colorectal cancer cell proliferation, invasion, and migration via a mechanism involving downregulation of the MEK/ERK/VEGF pathway, while overexpression of MEK reversed the beneficial effect of sophocarpine (Wang et al., 2019a). This evidence concerns the gene MAP2K7 and colorectal cancer.